Literature DB >> 20231548

Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan.

K C Hickling1, J M Hitchcock, J K Chipman, T G Hammond, J G Evans.   

Abstract

Cholangiofibrosis is a structural anomaly that precedes the development of cholangiocarcinoma in some rodent models. In this article, the authors examine the contribution of the epithelial and mesenchymal cells in the pathogenesis of this complex lesion. Furan was administered to rats by gavage in corn oil at 30 mg/kg b.w. (five daily doses per week) and livers were sampled between eight hr to three months. Characteristically the administration of furan caused centrilobular injury, and restoration was accomplished by proliferation of hepatocytes. Some areas of the liver were, however, more severely affected, and here, injury extended into portal and capsular areas, which resulted in a rapid proliferation of ductular cells that extended into the parenchyma accompanied by a subtype of liver fibroblasts. These ductules either differentiated into hepatocytes, with loss of the associated fibroblasts, or progressed to form tortuous ductular structures that replaced much of the parenchyma, leading to cholangiofibrosis. Although it is unclear what determines the difference in the hepatic response, a loss of micro-environmental cues that instigate hepatocyte differentiation and termination of the hepatocyte stem cell repair response may be perturbed by continual furan administration that results in an irreversible expansile lesion that may mimic the features of cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231548     DOI: 10.1177/0192623309357945

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  8 in total

1.  Mutagenicity of furan in female Big Blue B6C3F1 mice.

Authors:  Ashley N Terrell; Mailee Huynh; Alex E Grill; Ramesh C Kovi; M Gerard O'Sullivan; Joseph B Guttenplan; Yen-Yi Ho; Lisa A Peterson
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2014-06-02       Impact factor: 2.873

2.  Proceedings of the 2019 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Mark F Cesta; Torrie A Crabbs; Kyathanahalli S Janardhan; Gregory A Krane; Debabrata Mahapatra; Erin M Quist; Matthias Rinke; George W Schaaf; Gregory S Travlos; Haoan Wang; Cynthia J Willson; Jeffrey C Wolf
Journal:  Toxicol Pathol       Date:  2019-10-23       Impact factor: 1.902

3.  Detailed exposure assessment of dietary furan for infants consuming commercially jarred complementary food based on data from the DONALD study.

Authors:  Dirk W Lachenmeier; Elena Maser; Thomas Kuballa; Helmut Reusch; Mathilde Kersting; Ute Alexy
Journal:  Matern Child Nutr       Date:  2010-12-22       Impact factor: 3.092

4.  Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet.

Authors:  Ian Guest; Zoran Ilic; Stewart Sell
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 5.  Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.

Authors:  Jeffrey L Barnes; Yves Gorin
Journal:  Kidney Int       Date:  2011-02-09       Impact factor: 10.612

Review 6.  Reactive metabolites in the biotransformation of molecules containing a furan ring.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2012-10-24       Impact factor: 3.739

7.  Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.

Authors:  Fan Zhang; Lianhong Li; Xingwu Yang; Bo Wang; Jinyao Zhao; Shilun Lu; Xiaotang Yu
Journal:  J Toxicol Pathol       Date:  2015-02-09       Impact factor: 1.628

Review 8.  Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.

Authors:  Man Li; Xueli Zhou; Wei Wang; Baoan Ji; Yu Shao; Qianyu Du; Jinghao Yao; Yan Yang
Journal:  J Clin Transl Hepatol       Date:  2022-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.